Details for Patent: 11,406,623
Which drugs does patent 11,406,623 protect, and when does it expire?
Patent 11,406,623 protects EPIDIOLEX and is included in one NDA.
This patent has fourteen patent family members in eleven countries.
Summary for Patent: 11,406,623
| Title: | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
| Abstract: | The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus. |
| Inventor(s): | Geoffrey Guy, Volker Knappertz, Eduardo Dunayevich, David CRITCHLEY |
| Assignee: | Jazz Pharmaceuticals Research UK Ltd |
| Application Number: | US17/509,939 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 11,406,623 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 11,406,623
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms Res | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | 11,406,623 | ⤷ Start Trial | USE FOR THE TREATMENT OF SEIZURES ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX IN PATIENTS TAKING EVEROLIMUS | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,406,623
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2021227591 | ⤷ Start Trial | |||
| Canada | 3169026 | ⤷ Start Trial | |||
| China | 115209882 | ⤷ Start Trial | |||
| European Patent Office | 4110310 | ⤷ Start Trial | |||
| United Kingdom | 202002754 | ⤷ Start Trial | |||
| United Kingdom | 202102853 | ⤷ Start Trial | |||
| United Kingdom | 2593590 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
